PX20606 trans racemate is primarily utilized in pharmaceutical research and development, particularly in the study of neurological disorders. It serves as a key compound in the investigation of receptor activity and signaling pathways in the brain, aiding in the discovery of potential therapeutic agents for conditions such as anxiety, depression, and neurodegenerative diseases. Additionally, it is used in preclinical studies to evaluate its pharmacokinetics and pharmacodynamics, helping researchers understand its efficacy and safety profile. The compound also plays a role in the synthesis of analogs for structure-activity relationship (SAR) studies, contributing to the optimization of drug candidates.